eCARTv5 Clinical Deterioration Suite (“eCART”) vs Global Hypoperfusion Index (GHI) Algorithm

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
eCARTv5 Clinical Deterioration Suite (“eCART”)
by AgileMD
VS
Global Hypoperfusion Index (GHI) Algorithm
by Edwards Lifesciences

AI Verdict

Both are FDA-cleared, AI-powered clinical decision support tools. However, eCART focuses on predicting general clinical deterioration (death or ICU transfer) in hospitalized adult patients over several hours, integrating with EHRs. In contrast, the GHI Algorithm is specialized for critical care settings, predicting specific global hypoperfusion events 10-15 minutes in advance and requiring integration with advanced hemodynamic monitoring platforms.

Choose eCARTv5 Clinical Deterioration Suite (“eCART”) if…

Choose eCARTv5 if your hospital needs a comprehensive, enterprise-wide solution for continuous, AI-powered prediction of general clinical deterioration (death or ICU transfer) across all hospitalized adult patients. This tool is ideal for organizations seeking to embed clinical pathways, reduce false alarms, and proactively guide care hours before critical illness, aiming for improved patient outcomes and operational efficiency across multiple units.

View eCARTv5 Clinical Deterioration Suite (“eCART”) →

Choose Global Hypoperfusion Index (GHI) Algorithm if…

Choose the Global Hypoperfusion Index (GHI) Algorithm if your critical care unit requires highly specific, real-time, short-term predictions for global hypoperfusion events, particularly when utilizing advanced hemodynamic monitoring platforms with Swan-Ganz catheters. This tool is best suited for clinicians who need adjunctive information 10-15 minutes in advance to make timely, targeted interventions in high-acuity settings.

View Global Hypoperfusion Index (GHI) Algorithm →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) Global Hypoperfusion Index (GHI) Algorithm
Pricing Contact vendor for tailored quote. Contact for pricing
Deployment Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems. Integrated into compatible advanced hemodynamic monitoring platforms, such as the HemoSphere Alta™ Advanced Monitoring Platform.
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (“eCART”)

Tool A, eCARTv5, is designed for seamless integration with EHRs and includes embedded clinical pathways, aiming to minimize false alarms and clinician workload. User reviews highlight its intuitive interface and ability to streamline order entry and documentation, enhancing workflow efficiency.

Clinical Value

eCARTv5 Clinical Deterioration Suite (“eCART”)

Both tools are FDA-cleared, but eCARTv5 (Tool A) offers a broader clinical value by predicting all-cause clinical deterioration (death or ICU transfer) hours in advance, with extensive retrospective and prospective validation across millions of patient encounters. It also integrates actionable clinical pathways for direct care guidance.

Pricing & Value

Tie

Neither tool provides publicly available pricing details, requiring prospective customers to contact the respective vendors for tailored quotes. This lack of transparency makes a direct comparison of pricing or perceived value impossible.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (“eCART”)

eCARTv5 (Tool A) explicitly states HIPAA compliance and BAA availability, deploys as a cloud-based SaaS, and integrates directly into EHR systems, offering reporting and benchmarking capabilities. Its design emphasizes rapid and seamless implementation at scale.

Innovation

eCARTv5 Clinical Deterioration Suite (“eCART”)

While both use AI for prediction, eCARTv5 (Tool A) demonstrates broader innovation through its comprehensive, all-cause clinical deterioration prediction using up to 97 variables, its focus on minimizing false alarms, and its integration of actionable clinical pathways directly into EHR workflows for holistic patient management.

Support & Docs

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD (Tool A) offers comprehensive support, including a user forum, various training resources, and mentions of 24/7 live support, suggesting a robust and interactive support ecosystem. Edwards Lifesciences (Tool B) provides standard product documentation and customer service contacts, but AgileMD's offerings appear more extensive and interactive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) Global Hypoperfusion Index (GHI) Algorithm
Tool Name eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d) Global Hypoperfusion Index (GHI) Algorithm
Company AgileMD Edwards Lifesciences
Description FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. FDA-cleared AI tool that predicts the likelihood of global hypoperfusion events 10-15 minutes in advance, providing critical insights for proactive patient management in critical care settings.
Primary Prediction Focus Risk of clinical deterioration (death or ICU transfer) Likelihood of global hypoperfusion events
Key Feature 1 AI-powered clinical deterioration prediction Predicts global hypoperfusion events 10-15 minutes in advance
Key Feature 2 Continuous patient risk assessment (death or ICU transfer) Generates an index (0-100) indicating the likelihood of an event
Key Feature 3 EHR integration with real-time data (up to 97 variables) Utilizes a machine-learning model based on real-time patient health data

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (“eCART”) and Global Hypoperfusion Index (GHI) Algorithm.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A (eCARTv5) predicts the risk of clinical deterioration, defined as death or ICU transfer, in hospitalized adult patients. Tool B (Global Hypoperfusion Index Algorithm) predicts the likelihood of global hypoperfusion events in critical care settings.
eCARTv5 provides continuous patient risk assessment and is designed to alert clinicians hours before critical illness. The Global Hypoperfusion Index Algorithm predicts global hypoperfusion events 10-15 minutes in advance.
eCARTv5 is a cloud-based SaaS that integrates directly into Electronic Health Record (EHR) systems, leveraging up to 97 real-time variables. The Global Hypoperfusion Index Algorithm integrates into compatible advanced hemodynamic monitoring platforms, such as the HemoSphere Altau2122 Advanced Monitoring Platform, and is intended for use with a Swan-Ganz catheter.
eCARTv5 is intended for hospitalized adult patients across medical-surgical wards. The Global Hypoperfusion Index Algorithm is designed for surgical and non-surgical patients in critical care environments receiving advanced hemodynamic monitoring.
eCARTv5 generates an eCART score and risk designation, and guides care with embedded clinical pathways, aiming to minimize false alarms. The Global Hypoperfusion Index Algorithm generates an index (0-100) indicating the likelihood of an event and alerts clinicians when a risk threshold is reached, providing adjunctive information for clinical review.

More Comparisons

ChatGPT vs MCG Health
When considering AI tools, physicians can choose between general-purpose conversational AI like OpenAI's ChatGPT and specialized evidence-based guidance systems such…
eCARTv5 Clinical Deterioration Suite (“eCART”) vs Tempus AI
When considering AI tools for clinical practice, physicians can choose between broad deterioration prediction and specialized diagnostic analysis. AgileMD's eCARTv5…
ChatGPT vs Agentforce for Healthcare
When considering AI tools, physicians must weigh their primary needs. OpenAI's ChatGPT, particularly its specialized 'ChatGPT for Healthcare' enterprise version,…
ChatGPT vs Lumiata AI
When choosing between ChatGPT and Lumiata AI, physicians should consider their primary needs: general AI assistance and content generation versus…

More matchups featuring eCARTv5 Clinical Deterioration Suite (“eCART”) or Global Hypoperfusion Index (GHI) Algorithm

AI Tool Finder
AI-powered search. Results may not be comprehensive.